Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastric Cancer Stage × XELOX × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Rectal Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 2 Neoplasm Metastasis 1 Locally Advanced Rectal Cancer (LARC) 1 Gastric Cancer Stage 1 Adenocarcinoma of the Lower Rectum 1

Interventions

tislelizumab 1 XELOX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07068516 2025-07-16

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Zhejiang Cancer Hospital

Phase 3 Not yet recruiting

Gastrointestinal

Gastric Cancer Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡